RYTM Stock: Price, Earnings History and SEC Filings
Rhythm Pharmaceuticals, Inc. (RYTM) last traded at $92.57, down 0.54% on the latest session and down 2.8% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.73 against an analyst estimate of $-0.81, a beat of 9.9%.
$92.57 -0.54%
1 month-2.78%
52-week high$122.20
52-week low$74.50
Volume431,656
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
RYTM earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 4, 2026 | $-0.73 | $-0.81 | +9.88% |
| Mar 2026 | May 5, 2026 | $-0.83 | $-0.86 | +3.49% |
| Dec 2025 | Feb 26, 2026 | $-0.73 | $-0.79 | +7.59% |
| Sep 2025 | Nov 4, 2025 | $-0.82 | $-0.72 | -13.89% |
RYTM beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for RYTM
SEC filing data is not available right now. You can search for RYTM on SEC EDGAR.
RYTM news
- CAMP4 Therapeutics Corporation (CAMP) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseOct 29, 2026 · finance.yahoo.com
- Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseOct 27, 2026 · finance.yahoo.com
- Progressive (PGR) Upgraded to Buy: Here's WhyOct 22, 2026 · msn.com
- William Blair Expands Biotech Research as Veteran Analyst Alethia Young Initiates CoverageOct 21, 2026 · finance.yahoo.com
- Rhythm Pharmaceuticals to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026Oct 21, 2026 · finance.yahoo.com
About Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. (RYTM) is a US-listed public company on Nasdaq.